
Hims & Hers Stocks Slip After FDA Announces End to Semaglutide Shortage: What Does This Mean for Investors?
The Resolution of Semaglutide Injection Shortage: FDA’s Action Against Compounders The Food and Drug Administration (FDA) recently announced that the shortage of semaglutide injection products, including Novo Nordisk’s Ozempic and Wegovy, has been resolved. This news comes after months of scarcity that left many patients struggling to access these essential diabetes medications. The FDA’s announcement…